📰 Analyse Sample News
Analyse Sample News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Analyse Sample. Real-time updates on events, politics, business and more.
November 21, 2022
Shanghai Fosun Pharma announced it has licensed US rights to a PD-1 candidate from its longstanding partner Henlius Biotech in an $840 million agreement. Read more here...
August 21, 2022
Shares of clinical-stage biopharma Annexon are down by half since an early January 2022 data release revealed 5 of 28 patients dropped out of a Phase 2 Huntington’s disease study.